The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

 
Web www.patentalert.com

< NS5A nucleotide sequence variation as a marker for interferon response

> Cloned genome of infectious hepatitis C virus strain HC-TN and uses thereof

> Methods, kits and polynucleotides for simultaneously diagnosing viruses
~ 00501